In future, a more detailed understanding of the lung microbiome in pneumonia may enable improved diagnostics, prognosis, and therapeutics.

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

Musculoskeletal disorders and injuries are a leading cause of disability worldwide, severely affecting quality of life and creating a significant ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

Photoactive nanomaterials represent a dynamic and rapidly evolving area within nanobiotechnology, offering unique opportunities to manipulate cellular and ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

Novartis AG will pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases. The deal aims to combine Novartis’s expertise in ...

Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Read more at The ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...